Hypertension

• CLINICAL_TRIALS trial_result · 2023-08-14
  Clinical Trial Update: Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension [Phase 4]

  Phase 4 trial evaluating the effect of olmesartan on Angiotensin(1-7) levels and vascular functions in patients with diabetes and hypertensi…

• FDA approval · 2023-08-14
  FDA Approved: LOSARTAN POTASSIUM — Original Application (Novadoz Pharmaceuticals LLC)

  FDA approves the original application for losartan potassium (a generic product) by Novadoz Pharmaceuticals LLC.

• FDA approval · 2023-08-11
  FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal Pharmaceuticals LLC's generic valsartan/hydrochlorothiazide tablet for hypertension under an original application.

• FDA approval · 2023-08-10
  FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, a generic combination product for hypertension manu…

• FDA approval · 2023-08-10
  FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

  The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc., signali…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-08-07
  Clinical Trial Update: The Impact of Sharing Audio Recorded Clinic Visits on Self-management in Older Adults [NA]

  This update notes the completion and posting of results for a study evaluating whether sharing audio-recorded clinic visits improves self-ma…

• FDA approval · 2023-08-07
  FDA Approved: METOPROLOL SUCCINATE — Original Application (Granules India Ltd)

  FDA approved METOPROLOL SUCCINATE (extended-release) as an original generic application from Granules India Ltd, enabling its marketing for …

• FDA approval · 2023-07-31
  FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium and Hydrochlorothiazide, a combination product. The appr…

• FDA approval · 2023-07-28
  FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

  FDA approved a supplemental application for a generic losartan potassium and hydrochlorothiazide product from Macleods Pharmaceuticals Limit…

• FDA approval · 2023-07-26
  FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)

  FDA approved a supplemental application for COREG (carvedilol) submitted by Waylis Therapeutics LLC.

• FDA approval · 2023-07-21
  FDA Approved: TORSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for torsemide, granting approval of a generic torsemide product u…

• FDA approval · 2023-07-20
  FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

  The FDA approved a supplemental application for the generic combination medication losartan potassium and hydrochlorothiazide manufactured b…

• CLINICAL_TRIALS trial_result · 2023-07-18
  Clinical Trial Update: Low-dose Quadruple Combination Therapy in Patients With Hypertension [Phase 4]

  Phase 4 trial update on low-dose quadruple combination therapy for hypertension, completed.

• FDA approval · 2023-07-17
  FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Burel Pharmaceuticals, LLC)

  FDA approved the original application for NICARDIPINE HYDROCHLORIDE filed by Burel Pharmaceuticals, LLC, authorizing a generic version of ni…

• FDA approval · 2023-07-14
  FDA Approved: TELMISARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved Mylan's supplemental application for telmisartan (generic), enabling the generic telmisartan product to be marketed under the A…

• CLINICAL_TRIALS trial_result · 2023-07-14
  Clinical Trial Update: Occurrence of Dyskalemia With Treatment for Hypertension [Phase 4]

  Phase 4 trial update examining the occurrence of dyskalemia with treatment for hypertension.

• FDA approval · 2023-07-14
  FDA Approved: BISOPROLOL FUMARATE — Original Application (Solco Healthcare US, LLC)

  FDA approved the generic bisoprolol fumarate tablet from Solco Healthcare US for the treatment of hypertension.

• FDA approval · 2023-07-12
  FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (AvKARE)

  FDA approved a supplemental application for a generic fixed-dose combination of telmisartan and hydrochlorothiazide (AvKARE) for the treatme…

• FDA approval · 2023-07-12
  FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare US, LLC)

  FDA approved a supplemental application for a generic valsartan and hydrochlorothiazide product manufactured by Solco Healthcare US, LLC.

• CLINICAL_TRIALS trial_result · 2023-07-11
  Clinical Trial Update: Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE) [Phase 2]

  Phase 2 trial ASPPIRE investigating aspirin to prevent preeclampsia in women with elevated blood pressure and stage 1 hypertension was termi…

• FDA approval · 2023-07-10
  FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Xiamen LP Pharmaceutical Co., Ltd.)

  FDA approved a supplemental ANDA for clonidine hydrochloride from Xiamen LP Pharmaceutical Co., Ltd., granting approval for a generic clonid…

• FDA approval · 2023-07-05
  FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)

  FDA approved a supplemental application for Lopressor (metoprolol tartrate) submitted by Validus Pharmaceuticals LLC.

• CLINICAL_TRIALS trial_result · 2023-07-03
  Clinical Trial Update: Blood Pressure Lowering in Dialysis (BOLD) Trial [Phase 2]

  Phase 2 trial investigating blood pressure lowering strategies in patients with end-stage renal disease on dialysis; trial completed with re…

• FDA approval · 2023-06-26
  FDA Approved: TELMISARTAN — Supplemental Application (Solco Healthcare US, LLC)

  The FDA approved a supplemental application for a generic telmisartan product submitted by Solco Healthcare US, LLC. Telmisartan is used to …

• FDA approval · 2023-06-23
  FDA Approved: SPIRONOLACTONE — Supplemental Application (Oxford Pharmaceuticals, LLC)

  FDA approved a supplemental application for spironolactone by Oxford Pharmaceuticals, LLC. The approval allows continued marketing of the ge…